Figure 2.

Small molecule drugs (blue lines), biologics including vaccines (green lines), and monoclonal antibodies/Fc fusion proteins (red lines) approved by the United States Food and Drug Administration from 1997 to May 1, 2017. This information was sourced and extracted from the US FDA website (https://www.fda.gov/drugs/developmentapprovalprocess/druginnovation/ucm537040.htm)